Shinji Yamazaki

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Artificial Intelligence

Mycobacterium Tuberculosis

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shinji Nakayama, Kota Toshimoto, Shinji Yamazaki, Jan Snoeys, Yuichi Sugiyama
Physiologically-based pharmacokinetic modeling for investigating the effect of simeprevir on concomitant drugs and an endogenous biomarker of OATP1B. CPT: pharmacometrics & systems pharmacology (2023)
Jian Lin, Emi Kimito, Shinji Yamazaki, Manoli Vourvahis, Arthur Bergman, A David Rodrigues, Chester Costales, Rui Li, Manthena V S Varma
Effect of Hepatic Impairment on OATP1B Activity: Quantitative Pharmacokinetic Analysis of Endogenous Biomarker and Substrate Drugs. Clinical pharmacology and therapeutics (2022)
Shinji Yamazaki, Raymond Evers, Loeckie De Zwart
Physiologically-based pharmacokinetic modeling for primary metabolites of CYP3A and P-glycoprotein inhibitors in drug-drug interactions: Should we assume the free drug hypothesis? CPT: pharmacometrics & systems pharmacology (2022)
Jian Lin, Emi Kimito, Shinji Yamazaki, Manoli Vourvahis, Arthur Bergman, A David Rodrigues, Chester Costales, Rui Li, Manthena V S Varma
Effect of hepatic impairment on OATP1B activity: Quantitative pharmacokinetic analysis of endogenous biomarker and substrate drugs. Clinical pharmacology and therapeutics (2022)
Kristen Jensen-Pergakes, John Tatlock, Karen A Maegley, Indrawan J McAlpine, Michele A McTigue, Tao Xie, Christopher P Dillon, Yuli Wang, Shinji Yamazaki, Noah Spiegel, Manli Shi, Amy Nemeth, Natalie Miller, Eleanore Hendrickson, Hieu Lam, John Sherrill, Chi-Yeh Chung, Elizabeth A McMillan, Shannon Karlicek Bryant, Prakash Palde, John Braganza, Alexei Brooun, Ya-Li Deng, Vesta Goshtasbi, Susan E Kephart, Robert A Kumpf, Wei Liu, Ryan L Patman, Eugene Rui, Stephanie Scales, Michelle Tran-Dube, Fen Wang, Martin Wythes, Thomas A Paul
SAM Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance. Molecular cancer therapeutics (2021)
Xian Pan, Shinji Yamazaki, Sibylle Neuhoff, Mian Zhang, Venkatesh Pilla Reddy
Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P-glycoprotein-cytochrome P450 3A4 dual substrates. CPT: pharmacometrics & systems pharmacology (2021)
Chester Costales, Jian Lin, Emi Kimito, Shinji Yamazaki, James R Gosset, A David Rodrigues, Sarah Lazzaro, Mark A West, Michael West, Manthena V S Varma
Quantitative prediction of breast cancer resistant protein mediated drug-drug interactions using physiologically-based pharmacokinetic modeling. CPT: pharmacometrics & systems pharmacology 10 (9) (2021)